Medical Cannabis
Who Really Benefits from Britain’s Medical Cannabis System?
Written for Business of Cannabis by Saxon Coop, Founder & CEO of Toke.
NHS
18stories
30 Junlast updated
More in NHS
- Industry Trends
Why the UK’s Steady Medical Cannabis Market Growth Is Its Biggest Advantage
Though less explosive than markets like Germany or Australia, the UK has continued to evolve in a more controlled manner, enabling it to largely avoid the scrutiny and intervention that have accompanied rapid expansion elsewhere.
- Medical Cannabis
‘Valuable’ UK Medical Cannabis Data to be Published After A Four Year Delay
The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end of the year’.
- Data & Analysis
Hundreds of UK Families Forced to Turn to Illicit Cannabis Market Due to Lack of NHS Access
This story was first reported on Cannabis Health News. Hundreds of families in the UK are giving their children illegal cannabis products due to a lack of access on the NHS, according to a new report.
- Opinion
From Specialists to GPs: Releaf on Expanding Access to Medical Cannabis Training in the UK
Business of Cannabis recently sat down with Releaf’s Chief Operating Officer, Graham Woodward, a trained psychiatric nurse and former clinical director and CQC Specialist Advisor, to discuss the impact of the lack of access to training how clinics such as Releaf are working to change it.
- Medical
Parents of Children with Epilepsy Demand Urgent NHS Reform for Cannabis Access
Families from across the UK returned to Westminster on Tuesday 5 November, clutching photos of their loved ones, along with stories and testimonies from dozens of patients who say they are thriving thanks to cannabis-based medicines.
- Press releases
NHS Failing to Provide Medical Cannabis for Patients in Need, Says CIC
The NHS is failing to prescribe cannabis flower medication to any patients, including those with conditions such as epilepsy, chronic pain, and cancer, according to new research from the Cannabis Industry Council (CIC).
- Medical
UK Launches 2 Clinical Trials into Cannabis and Childhood Epilepsy, But Serious Concerns Raised Over its Structure
Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy.
- Press releases
Script Assist’s Advanced Technology to Power CB1 Medical’s Patient Services
Script Assist, a digital platform for medical cannabis prescribing, is excited to announce that CB1 Medical will be the first UK mainland clinic to go live with its Software as a Service (SaaS) platform in August.
